SCHEMBL8895101

SCHEMBL8895101

CCOC(=O)c1ccc(OSc2cc3c(cc2C)C(C)(C)CCC3(C)C)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 12/20 0.50
RXRG P48443 9/20 0.50
RXRB P28702 8/20 0.50
RARA P10276 6/20 0.50
RARB P10826 6/20 0.50
RARG P13631 3/20 0.47
CYP3A4 P08684 2/20 0.42
ESR1 P03372 2/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
ESR2 Q92731 1/20 0.41
CA14 Q9ULX7 1/20 0.41
STS P08842 1/20 0.41
MEN1 O00255 1/20 0.41
CYP26A1 O43174 1/20 0.41
ABCB11 O95342 1/20 0.41
PGR P06401 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8895750 0.85 RXRA (0.68) RXRARXRGRXRBRARARARB
SCHEMBL8015924 0.84 RXRA (0.71) RXRARXRGRXRBRARARARB
SCHEMBL8896356 0.83 RARB (0.53) RXRARXRGRXRBRARARARB
SCHEMBL9551743 0.79 RARA (0.74) RXRARXRGRXRBRARARARB
SCHEMBL8017935 0.77 RXRA (0.74) RXRARXRGRXRBRARARARB
SCHEMBL6890269 0.77 RXRA (0.70) RXRARXRGRXRBRARARARB
SCHEMBL3819796 0.76 RARB (0.60) RXRARXRGRXRBRARARARB
SCHEMBL8005372 0.76 RXRA (0.56) RXRARXRGRXRBRARARARB
SCHEMBL9551786 0.76 RARB (0.63) RXRARXRGRXRBRARARARB
SCHEMBL9551782 0.75 RARB (0.71) RXRARXRGRXRBRARARARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5672710-A SPECIFIC AGONISTS FOR THE RXR RETINOID RECEPTOR RATHER THAN THE RAR ONE; SIDE EFFECT REDUCTION; SKIN AND NERVOUS SYTEM DISORDERS; ANTICARCINOGENIC AGENTS; VISION DEFECTS ALLERGAN (US) 1997-09-30 US disclosed
WO-1997016422-A1 SULFIDES, SULFOXIDES AND SULFONES DISUBSTITUTED WITH A TETRAHYDRONAPHTHALENYL, CHROMANYL, THIOCHROMANYL OR TETRAHYDROQUINOLINYL AND SUBSTITUTED PHENYL OR HETEROARYL GROUP, HAVING RETINOID-LIKE BIOLOGICAL ACTIVITY ALLERGAN (US) 1997-05-09 WO disclosed